Literature DB >> 24817029

Amikacin dosing in the ICU: we now know more, but still not enough….

Francesco G De Rosa1, Jason A Roberts.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24817029     DOI： 10.1007/s00134-014-3308-6

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  6 in total

1.  Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25 mg/kg total body weight regimen.

Authors:  Etienne de Montmollin; Lila Bouadma; Nathalie Gault; Bruno Mourvillier; Eric Mariotte; Sarah Chemam; Laurent Massias; Emmanuelle Papy; Florence Tubach; Michel Wolff; Romain Sonneville
Journal:  Intensive Care Med       Date:  2014-04-01       Impact factor: 17.440

2.  Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: lessons from the DALI Study.

Authors:  J A Roberts; V Stove; J J De Waele; B Sipinkoski; B McWhinney; J P J Ungerer; M Akova; M Bassetti; G Dimopoulos; K-M Kaukonen; D Koulenti; C Martin; P Montravers; J Rello; A Rhodes; T Starr; S C Wallis; J Lipman
Journal:  Int J Antimicrob Agents       Date:  2014-02-22       Impact factor: 5.283

3.  Quantification of lean bodyweight.

Authors:  Sarayut Janmahasatian; Stephen B Duffull; Susan Ash; Leigh C Ward; Nuala M Byrne; Bruce Green
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 4.  Using PK/PD to optimize antibiotic dosing for critically ill patients.

Authors:  Jason A Roberts
Journal:  Curr Pharm Biotechnol       Date:  2011-12       Impact factor: 2.837

5.  Antibiotic dosing in the 'at risk' critically ill patient: Linking pathophysiology with pharmacokinetics/pharmacodynamics in sepsis and trauma patients.

Authors:  Jason A Roberts; Michael S Roberts; Andrew Semark; Andrew A Udy; Carl Mj Kirkpatrick; David L Paterson; Matthew J Roberts; Peter Kruger; Jeffrey Lipman
Journal:  BMC Anesthesiol       Date:  2011-02-20       Impact factor: 2.217

6.  DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients?

Authors:  Jason A Roberts; Sanjoy K Paul; Murat Akova; Matteo Bassetti; Jan J De Waele; George Dimopoulos; Kirsi-Maija Kaukonen; Despoina Koulenti; Claude Martin; Philippe Montravers; Jordi Rello; Andrew Rhodes; Therese Starr; Steven C Wallis; Jeffrey Lipman
Journal:  Clin Infect Dis       Date:  2014-01-14       Impact factor: 9.079
  6 in total
  1 in total

1.  Extracorporeal membrane oxygenation (ECMO) does not impact on amikacin pharmacokinetics: a case-control study.

Authors:  E Gélisse; M Neuville; E de Montmollin; L Bouadma; B Mourvillier; J F Timsit; R Sonneville
Journal:  Intensive Care Med       Date:  2016-03-24       Impact factor: 17.440
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.